Table 4 Baseline patient demographic and disease characteristics in patients who evaluated for liver fibrosis
Characteristics | Mesenchymal patients (n = 47, 61%) | Non-mesenchymal patients (n = 30, 39%) | P value | |
|---|---|---|---|---|
Age (years), mean (P25–P75) | 15.4 (10.94–16.81) | 11.5 (5.73–15.13) | 0.019 | |
Patient sex, n (%) | Male | 27 (57.5%) | 10 (33.3%) | 0.039 |
Female | 20 (42.5%) | 20 (66.7%) | ||
Donor sex, n (%) | Male | 25 (53.2%) | 10 (38.5%) | 0.228 |
Female | 22 (46.8%) | 16 (61.5%) | ||
Sex match status, n (%) | Sex-mismatch | 26 (55.3%) | 10 (38.5%) | 0.168 |
Sex-match | 21 (44.7%) | 16 (61.5%) | ||
ABO match status, n (%) | ABO-mismatched | 18 (39.1%) | 7 (25%) | 0.213 |
ABO-matched | 28 (60.9%) | 21 (75%) | ||
Source of HSCT, n (%) | BM | 14 (29.8%) | 14 (46.7%) | 0.133 |
PB | 33 (70.2%) | 16 (53.3%) | ||
Acute GvHD, n (%) | No | 21 (44.7%) | 17 (56.7%) | 0.305 |
Yes | 26 (55.3%) | 13 (43.3%) | ||
Chronic GvHD, n (%) | No | 24 (51%) | 16 (53.3%) | 0.846 |
Yes | 23 (49%) | 14 (46.7%) | ||
WBC (× 108/kg), mean (P25–P75) | 8.38 (6.07–10.24) | 7.13 (5.7–9.67) | 0.732 | |
MNC (× 108/kg), mean (P25–P75) | 7.41 (3.3–8.11) | 4.35 (2.71–8.22) | 0.427 | |
CD3 cell (× 106/kg), mean (P25–P75) | 236.8 (76.02–335.6) | 83.86 (62.3–269) | 0.126 | |
CD34 cell (× 106/kg), mean (P25–P75) | 4.23 (2.6–6.42) | 3.59 (2.8–8.07) | 0.837 | |
ANC engraftment (days), mean (P25–P75) | 16.8 (14–21) | 18.1 (15–24) | 0.764 | |
Platelets engraftment (days), mean (P25–P75) | 25.8 (21–32) | 35.6 (24–51) | 0.273 | |